Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures ...
Stanford researchers have developed Microbe-Independent Deep Assembly and Screening – MIDAS – a polymerase chain ...
(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
Proteins are critical to life – and to industry. There are countless proteins that could be engineered to treat and even cure serious diseases and cellular dysfunctions. Industrial applications are ...
SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced the United States Patent and Trademark ...
Primary cardiomyopathies (CMPs) are monogenic but multi-allelic disorders with dozens of genes involved in pathogenesis. The implementation of next-generation sequencing (NGS) approaches has resulted ...
Correspondence to Dr Benjamin A Pinsky, Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; bpinsky{at}stanford.edu Methods Lower limits of detection for the B1 ...
Background Tuberculous pleurisy (TBP) is a leading aetiology of exudative pleural effusion in tuberculosis (TB)-endemic regions and poses significant diagnostic challenges due to its paucibacillary ...
The University at Buffalo Clinical and Translational Science Institute is headquartered in the Clinical and Translational Research Center (CTRC) on the growing Buffalo Niagara Medical Campus. The ...
At the core of a new diagnostic test created by ASU researchers are tiny gold nanoparticles, engineered to detect extremely small amounts of disease-related proteins. The device is so sensitive that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results